Tirzepatide $199
Metabolic health & appetite support
Pharmacy economics that protect your margin
We own a 503A compounding pharmacy and offer a national 503A/503B network with standardized formulations and pre-negotiated pricing, giving you predictable costs and greater control over margin.
Two pharmacy models. One flexible network.
Two pharmacy models, one flexible network. Our 503A pharmacy supports patient-specific compounding, while our 503B network adds batch production capabilities. Together, they give you broader product options, nationwide coverage, supply resiliency, and greater flexibility across fulfillment.
| 503A Pharmacies | 503B Pharmacies | |
|---|---|---|
| Regulated by | State board of pharmacy | FDA, plus the state board where it sits |
| What it makes | One prescription, for one named patient | Batches, with or without a patient script |
| Standard | USP chapters 795 and 797 | Current good manufacturing practice |
| Testing | Per the USP chapter it works to | Release testing and stability, batch by batch |
| Inspected | State board, with the FDA on a risk basis | FDA, on a routine risk-based schedule |
| Ships | Where it holds a license | Across state lines |
A slow partner is a reroute, not a refund email
Fifty states, reachable through licensing and provider coverage, with partner capacity sitting behind our own pharmacy. Routing picks on capacity and speed, so when one door slows the volume moves to the next one before a patient ever hears about it.
Order routing
Routed on capacity and speedOrders in
-
Our pharmacy
+ Routed -
Partner A
+ Routed -
Partner B
Held -
Partner C
+ Routed
One vial, unchanged
We know what the vial costs, because we make it
Every other platform in this category brokers supply from a pharmacy it does not own. That saves you a negotiation, but it leaves the counterparty, the second margin and the price volatility exactly where they were. We negotiate the partner network against a number we already have, so the margin is managed rather than inherited.
Where the margin goes
The usual wayWhat does not move
With Launch- Your price
- Supply requoted each quarter
Line chart across five doses from 0.25 mg to 2.5 mg. Your price stays flat at every dose, while brokered supply that is requoted each quarter rises steadily as the dose increases.
You are buying from a company that fills prescriptions, not one that marks them up.
Run your own volume →We know what your business needs. We built the stack to match.
-
Consumer Brands
You have the customers and the brand they trust. We add the healthcare infrastructure behind the scenes, giving you a way to expand into a new category without becoming a pharmacy.
Turn your audience into a new revenue stream.
-
MedSpas & Clinics
You have the patients and the providers to prescribe for them. We add the pharmacy, support team, and a provider portal, and the records stay yours to own and control.
Your patients. Your records. Our pharmacy.
-
Telehealth
You already have the audience, the care model, and the patient relationship. We add the fulfillment infrastructure and support team to expand your offerings and create more revenue opportunities.
Add fulfillment. Control your margin.
See your numbers
Create a partner account and run your own volume and dose mix through the configurator; the vial price and the partnership terms are inside. If you would rather start with a conversation, book a demo and bring whoever holds the veto.